| Product Name | Etoposide (Synonyms: VP-16; VP-16-213;VP-16213) |
|---|---|
| CAS | 33419-42-0 |
| Formula | C26H33FN4O7 |
| MW | 532.56 |
| Appearance | White to off-white powder |
| Storage condition | 4°C, protect from light |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 25 mg | In-stock | $50.00 | Visible after login | |
| 50 mg | In-stock | $60.00 | Visible after login | |
| 100 mg | In-stock | $76.00 | Visible after login | |
| 250 mg | In-stock | $86.00 | Visible after login | |
| 500 mg | In-stock | $106.00 | Visible after login |
| Product Name | Etoposide (Synonyms: VP-16; VP-16-213;VP-16213) |
|---|---|
| CAS | 33419-42-0 |
| Formula | C26H33FN4O7 |
| MW | 532.56 |
| Appearance | White to off-white powder |
| Storage condition | 4°C, protect from light |
Etoposide (formerly VP-16, VP-16213; Toposar; VePesid; Lastet; EPEG), a chemotherapeutic drug used for the treatments of various cancers, is a semisynthetic derivative of the naturally occuring podophyllotoxin which inhibits DNA synthesis via topoisomerase II inhibitory activity.
Tags: buy Etoposide | Etoposide supplier | purchase Etoposide | Etoposide cost | Etoposide manufacturer | order Etoposide | Etoposide distributor
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.Cell Rep.
PMID: 31940492 DOI: 10.1016/j.celrep.2019.12.032
Etoposide-Anti-Human VEGF a new strategy against human melanoma cells expressing stem-like traits.
PMID: 27303923 PMCID: PMC5239464 DOI: 10.18632/oncotarget.9939
PMID: 27473919 DOI: 10.1016/j.tiv.2016.07.018